BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Primrose Bio Launches Prima RNApols™ ExTend Cap AU to Enhance Self-Amplifying mRNA Vaccine Manufacturing

Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, announced the launch of Prima RNApols™ ...

November 11, 2025 | News

Insilico Medicine and Eli Lilly Expand Collaboration to Accelerate AI-Driven Drug Discovery

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced a research collabor...

November 11, 2025 | News

ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...

November 11, 2025 | News

Top Global Proficiency Testing Companies Setting New Standards in Laboratory Accuracy

Proficiency testing (PT) is a form of external quality assurance in which laboratories analyze identical samples and compare results to evaluate performanc...

November 10, 2025 | News

Eli Lilly Partners with SanegeneBio to Advance RNAi Therapies for Metabolic Diseases

-Companies will collaborate on RNAi research for metabolic disease targets SanegeneBio, a clinical-stage biotechnology company developing innov...

November 10, 2025 | News

PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...

November 07, 2025 | News

Nona Biosciences Expands Partnership with Umoja Biopharma to Advance Next-Generation In Vivo CAR-T Therapies

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), announced an evaluation and licen...

November 06, 2025 | News

iLeukon’s mRNA IL-2 Therapy ILKN421H Achieves 80% Response Rate in Lung Cancer Trial

ILKN421H is a novel lipid nanoparticle (LNP)-formulated mRNA encoding a non-alpha HSA–IL-2v fusion protein and dominantly expressed in lymphoid org...

November 05, 2025 | News

AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer

First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO...

November 05, 2025 | News

Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...

November 05, 2025 | News

Phenomix’s MyPhenome Test Validates GLP-1 Response Prediction Across 88,000 Patients

Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in ...

November 05, 2025 | Report

MilliporeSigma and Promega Forge Strategic Partnership to Advance Next-Generation Drug Discovery

Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies. Aims to improve researcher acces...

November 04, 2025 | News

ICHORtec Expands Collaboration with Johns Hopkins to Advance Quantum-Driven Precision in CRISPR Gene Editing

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newb...

October 30, 2025 | News

Suvoda Launches Unified Patient App to Simplify Clinical Trial Participation and Boost Retention

Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions t...

October 30, 2025 | News

Stay Connected